A detailed history of Pro Share Advisors LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 47,459 shares of BLUE stock, worth $15,186. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,459
Previous 37,399 26.9%
Holding current value
$15,186
Previous $36,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.47 - $1.35 $4,728 - $13,581
10,060 Added 26.9%
47,459 $24,000
Q2 2024

Aug 13, 2024

SELL
$0.85 - $1.26 $8,794 - $13,035
-10,346 Reduced 21.67%
37,399 $36,000
Q1 2024

May 08, 2024

BUY
$0.91 - $1.75 $20,971 - $40,330
23,046 Added 93.31%
47,745 $61,000
Q4 2023

Feb 14, 2024

BUY
$1.32 - $4.83 $5,021 - $18,373
3,804 Added 18.21%
24,699 $34,000
Q3 2023

Nov 13, 2023

BUY
$3.02 - $4.05 $274 - $368
91 Added 0.44%
20,895 $63,000
Q2 2023

Aug 10, 2023

BUY
$2.79 - $5.03 $4,293 - $7,741
1,539 Added 7.99%
20,804 $68,000
Q1 2023

May 11, 2023

BUY
$3.14 - $8.22 $5,416 - $14,179
1,725 Added 9.83%
19,265 $61,000
Q4 2022

Feb 02, 2023

BUY
$5.77 - $8.49 $14,644 - $21,547
2,538 Added 16.92%
17,540 $121,000
Q3 2022

Nov 04, 2022

BUY
$3.75 - $7.39 $5,250 - $10,346
1,400 Added 10.29%
15,002 $95,000
Q2 2022

Aug 01, 2022

SELL
$2.94 - $5.23 $18,577 - $33,048
-6,319 Reduced 31.72%
13,602 $56,000
Q1 2022

May 10, 2022

SELL
$4.07 - $10.6 $19,173 - $49,936
-4,711 Reduced 19.13%
19,921 $96,000
Q4 2021

Feb 08, 2022

BUY
$8.96 - $16.31 $13,780 - $25,084
1,538 Added 6.66%
24,632 $247,000
Q3 2021

Nov 12, 2021

SELL
$11.24 - $21.0 $101,002 - $188,706
-8,986 Reduced 28.01%
23,094 $441,000
Q2 2021

Aug 13, 2021

BUY
$18.04 - $22.09 $388,401 - $475,597
21,530 Added 204.08%
32,080 $1.03 Million
Q1 2021

May 14, 2021

SELL
$16.59 - $33.89 $14,682 - $29,992
-885 Reduced 7.74%
10,550 $318,000
Q4 2020

Feb 09, 2021

SELL
$27.5 - $37.92 $10,532 - $14,523
-383 Reduced 3.24%
11,435 $495,000
Q3 2020

Nov 13, 2020

BUY
$34.44 - $43.75 $14,774 - $18,768
429 Added 3.77%
11,818 $638,000
Q2 2020

Aug 03, 2020

BUY
$27.12 - $45.97 $74,878 - $126,923
2,761 Added 32.0%
11,389 $695,000
Q1 2020

May 15, 2020

SELL
$26.16 - $63.5 $121,931 - $295,973
-4,661 Reduced 35.07%
8,628 $397,000
Q4 2019

Feb 12, 2020

SELL
$46.96 - $61.67 $139,518 - $183,221
-2,971 Reduced 18.27%
13,289 $1.17 Million
Q3 2019

Nov 12, 2019

SELL
$59.47 - $93.1 $69,460 - $108,740
-1,168 Reduced 6.7%
16,260 $1.49 Million
Q2 2019

Aug 13, 2019

SELL
$75.84 - $105.21 $261,268 - $362,448
-3,445 Reduced 16.5%
17,428 $2.22 Million
Q1 2019

May 15, 2019

BUY
$64.44 - $104.11 $46,590 - $75,271
723 Added 3.59%
20,873 $3.28 Million
Q4 2018

Feb 14, 2019

SELL
$59.1 - $93.26 $222,688 - $351,403
-3,768 Reduced 15.75%
20,150 $2 Million
Q3 2018

Nov 14, 2018

BUY
$88.86 - $117.49 $147,329 - $194,798
1,658 Added 7.45%
23,918 $3.49 Million
Q2 2018

Aug 13, 2018

SELL
$99.64 - $127.59 $836,079 - $1.07 Million
-8,391 Reduced 27.38%
22,260 $3.49 Million
Q1 2018

May 14, 2018

SELL
$105.8 - $150.94 $277,936 - $396,519
-2,627 Reduced 7.89%
30,651 $5.23 Million
Q4 2017

Feb 14, 2018

BUY
$81.25 - $130.7 $274,218 - $441,112
3,375 Added 11.29%
33,278 $5.93 Million
Q3 2017

Nov 13, 2017

BUY
$57.74 - $91.42 $254,517 - $402,979
4,408 Added 17.29%
29,903 $4.11 Million
Q2 2017

Aug 11, 2017

BUY
N/A
25,495
25,495 $2.68 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $24.7M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.